Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, et al. The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120:2611–9.
Altaweel M, Ip M. Macular hole: improved understanding of pathogenesis, staging, and management based on optical coherence tomography. Semin Ophthalmol. 2003;18:58–66.
Chatziralli IP, Theodossiadis PG, Steel DHW. Internal limiting membrane peeling in macular hole surgery; why, when, and how? Retina. 2018;38:870–82.
Gu C, Qiu Q. Inverted internal limiting membrane flap technique for large macular holes: a systematic review and single-arm meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2018;256:1041–9.
Kumar A, Tinwala SI, Gogia V, Sehra SV. Tapping of macular hole edges: the outcomes of a novel technique for large macular holes. Asia Pac J Ophthalmol (Phila). 2013;2:305–9.
Peng J, Chen C, Zhang H, Zhang L, Liu J, Ren J, et al. Long-term surgical outcomes of lens capsular flap transplantation in the management of refractory macular hole. Retina. 2021;41:726–34.
Article CAS PubMed Google Scholar
Zhang H, Li Y, Chen G, Han F, Jiang W. Human amniotic membrane graft for refractory macular hole: a single-arm meta-analysis and systematic review. J Fr Ophtalmol. 2023;46:276–86.
Ch’ng SW, Patton N, Ahmed M, Ivanova T, Baumann C, Charles S, et al. The Manchester large macular hole study: is it time to reclassify large macular holes? Am J Ophthalmol. 2018;195:36–42.
Romano MR, Rossi T, Borgia A, Catania F, Sorrentino T, Ferrara M. Management of refractory and recurrent macular holes: a comprehensive review. Surv Ophthalmol. 2022;67:908–31.
Sulkes DJ, Smiddy WE, Flynn HW, Feuer W. Outcomes of macular hole surgery in severely myopic eyes: a case-control study. Am J Ophthalmol. 2000;130:335–9.
Article CAS PubMed Google Scholar
Tam ALC, Yan P, Gan NY, Lam WC. The current surgical management of large, recurrent, or persistent macular holes. Retina. 2018;38:1263–75.
Buzzi M, Parisi G, Marolo P, Gelormini F, Ferrara M, Raimondi R, et al. The short-term results of autologous platelet-rich plasma as an adjuvant to re-intervention in the treatment of refractory full-thickness macular holes. J Clin Med. 2023;12:2050.
Article PubMed PubMed Central Google Scholar
Figueroa MS, Mora Cantallops A, Virgili G, Govetto A. Long-term results of autologous plasma as adjuvant to pars plana vitrectomy in the treatment of high myopic full-thickness macular holes. Eur J Ophthalmol. 2021;31:2612–20.
Kim M, Won JY, Choi SY, Kim M, Ra H, Jee D, et al. Therapeutic efficacy of autologous platelet concentrate injection on macular holes with high myopia, large macular holes, or recurrent macular holes: a multicenter randomized controlled trial. J Clin Med. 2021;10:2727.
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Xu Z, Zhao X, Meng L, Yang J, Chen Y. Therapeutic effect of using autologous platelet concentrate in vitrectomy for macular hole: a systematic review and meta-analysis. Retina. 2023;43:1833–41.
Ngah NA, Dias GJ, Tong DC, Mohd Noor SNF, Ratnayake J, Cooper PR, et al. Lyophilised platelet-rich fibrin: physical and biological characterisation. Molecules. 2021;26:7131.
Article CAS PubMed PubMed Central Google Scholar
Arias JD, Hoyos AT, Alcántara B, Sanchez-Avila RM, Arango FJ, Galvis V. Plasma rich in growth factors for persistent macular hole: a pilot study. Retin Cases Brief Rep. 2022;16:155–60.
Shpak AA, Shkvorchenko DO, Krupina EA. Surgical treatment of macular holes with and without the use of autologous platelet-rich plasma. Int Ophthalmol. 2021;41:1043–52.
Morescalchi F, Costagliola C, Gambicorti E, Duse S, Romano MR, Semeraro F. Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery. Surv Ophthalmol. 2017;62:58–69.
Wu AL, Liu YT, Chou HD, Chuang LH, Chen KJ, Chen YP, et al. Role of growth factors and internal limiting membrane constituents in müller cell migration. Exp Eye Res. 2021;202:108352.
Article CAS PubMed Google Scholar
Gupta S, Paliczak A, Delgado D. Evidence-based indications of platelet-rich plasma therapy. Expert Rev Hematol. 2021;14:97–108.
Article CAS PubMed Google Scholar
Mehta S, Watson JT. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma. 2008;22:432–8.
Mishra A, Velotta J, Brinton TJ, Wang X, Chang S, Palmer O, et al. RevaTen platelet-rich plasma improves cardiac function after myocardial injury. Cardiovasc Revasc Med. 2011;12:158–63.
Nadelmann JB, Bunya VY, Ying GS, Hua P, Massaro-Giordano M. Effect of autologous platelet-rich plasma drops in the treatment of ocular surface disease. Clin Ophthalmol. 2022;16:4207–13.
Article PubMed PubMed Central Google Scholar
Campochiaro PA, Hackett SF, Vinores SA, Freund J, Csaky C, LaRochelle W, et al. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci. 1994;107(Pt 9):2459–69.
Article CAS PubMed Google Scholar
Chang YC, Lin WN, Chen KJ, Wu HJ, Lee CL, Chen CH et al. Correlation between the dynamic postoperative visual outcome and the restoration of foveal microstructures after macular hole surgery. Am J Ophthalmol. 2015;160:100-6.e1.
Oh J, Yang SM, Choi YM, Kim SW, Huh K. Glial proliferation after vitrectomy for a macular hole: a spectral domain optical coherence tomography study. Graefes Arch Clin Exp Ophthalmol. 2013;251:477–84.
Madreperla SA, Geiger GL, Funata M, de la Cruz Z, Green WR. Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology. 1994;101:682–6.
Comments (0)